Clinical Trials Logo

Keratitis clinical trials

View clinical trials related to Keratitis.

Filter by:

NCT ID: NCT02186431 Completed - Keratitis Clinical Trials

Contact Lenses and Infiltrative Keratitis

CLIK
Start date: July 2014
Phase: N/A
Study type: Interventional

To quantify and compare baseline tear proteins and ocular response in contact lens wearers with a history of corneal infiltrative events, to those without a history of complications. This will be accomplished via measurement of select anti-inflammatory tear proteins before, during and after contact lens wear.

NCT ID: NCT02151305 Completed - Cataract Clinical Trials

Different Hemostasis According to the Anesthetic Agents

Start date: August 2010
Phase: N/A
Study type: Interventional

We investigated the hemostatic differences according to the main anesthetic agents by analyzing rotational thromboelastometry (ROTEM) under the hypothesis that propofol-based anesthesia would impair postoperative coagulability more than the sevoflurane-based anesthesia.

NCT ID: NCT02116062 Terminated - Pterygium Clinical Trials

Robotic Surgery of the Ocular Surface

Start date: June 2014
Phase: N/A
Study type: Interventional

The introduction of surgical robots in the OR revolutionized a number of specialties (i. e. urology, gynecology, digestive surgery). Robots are currently used in many situations and the list of appropriate indications is growing rapidly. There are many potential advantages of robotics in eye surgery such as increased precision and maneuverability, better ergonomics, improved patient access to surgeons and surgical training. As a result, robotics might improve patient care. The Da Vinci© robot has been used for 10 years in experimental conditions to suture corneal lacerations, to perform corneal grafts, to remove ocular foreign bodies, lens capsules and vitreous. The authors reported a lack of precision resulting from poor visualization and the absence of microsurgical instruments. These elements were considered to be hurdles to further clinical investigation. The new Da Vinci Si HD© robot has been available since 2009 at the IRCAD center and more recently in Strasbourg University Hospital. It provides greater magnification and better resolution of the operative field than the previous model. We performed since 2012 various ocular surface surgeries on porcine eyes at the IRCAD center. The aim of the present trial is to perform the same procedures (amniotic membrane transplantations, pterygium surgeries, corneal grafts) in a clinical setting with the Da Vinci Si HD© system.

NCT ID: NCT02088970 Terminated - Bacterial Keratitis Clinical Trials

Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)

CXL
Start date: September 2014
Phase: N/A
Study type: Interventional

The corneal collagen cross linking is currently used in the treatment of keratoconus but this procedure has also a sterilizing non-specific effect on bacteria and fungus. So the corneal cross linking in association with the antibiotic treatment could result in a reduction of the duration of epithelial complete healing of the cornea.

NCT ID: NCT02045082 Terminated - Clinical trials for Herpes Simplex Keratitis

The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis

Start date: October 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare a corneal sampling realized by a flocked swab (flocked swab regular 519CS01) with a sampling by traditional fiber swab (Copan regular swab 164KS01 in polyester). Their impact on the sensibility of the viral culture in the Herpes simplex epithelial keratitis will be the primary objective of this study.

NCT ID: NCT02016989 Recruiting - Bacterial Keratitis Clinical Trials

Matrix Therapy And Bacterial Keratitis

CACICOL
Start date: November 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate efficiency of CACICOL20 for bacterial keratitis. It is a double blinded comparison of epithelial defect in two groups of patients randomized between CACICOL20 and physiological salt solution.

NCT ID: NCT01925846 Recruiting - Clinical trials for Keratitis; Infectious Disease (Manifestation)

Pseudomonal Type Three Secretion System and Contact Lens Associated Microbial Keratitis

Start date: January 2013
Phase: N/A
Study type: Observational

Microbial infection of the cornea, also known as microbial keratitis, causes severe corneal inflammation that could result in permanent visual loss. Contact lens wear is the strongest risk factor related to microbial keratitis in developed countries. The most commonly isolated pathogen of contact lens associated microbial keratitis (CLMK) is Pseudomonas aeruginosa, which accounts for over one third of the cases. Among the various virulence factors involved in the pathogenesis of pseudomonal keratitis, a secretion system known as type three secretion system (T3SS) secretes toxins that damage the host cells. ExoS is a bifunctional exotoxin with GTPase-activating protein (GAP) activity and ADP ribosyl transferase (ADPRT) activity. It results in an invasive phenotype of P. aeruginosa causing a relatively slower host cell death with intracellular invasion and possibly proliferation of bacterium. In contrast, ExoU expressing strains carries a cytotoxic phenotype that causes rapid host cell lysis due to its phospholipase activity. Previously, cytotoxic strains were reported to be more commonly found in patients with pseudomonal keratitis and were highly correlated with multidrug resistance. In order to understand the pathogenesis of CLMK, especially pseudomonal related CLMK, we proposed to recruit 180 volunteers who will wear different contact lens materials. We then collect the used contact lens and analyze 1) the microbiota on the used contact lens; 2) the bacterial-contact lens adhesion of wild strains, pscC mutant strains (T3SS needle-comples mutant), cytotoxic strain, and invasive strain P. aeruginosa; 3) the effect of shearing forces on bacterial-contact lens adhesion; 4) the bacteriocidal effect of multipurpose solution on different strains of P. aeruginosa.

NCT ID: NCT01831206 Completed - Bacterial Keratitis Clinical Trials

Collagen Cross-linking in Infectious Keratitis Trial

Start date: March 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.

NCT ID: NCT01794312 Completed - Keratitis Clinical Trials

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Start date: February 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of T4020 versus vehicle.

NCT ID: NCT01756456 Completed - Keratitis Clinical Trials

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

REPARO
Start date: January 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This study is aimed at assessing the safety and the efficacy of two dose regimens of recombinant human nerve growth factor (rhNGF) eye drops solution compared to vehicle for inducing a complete healing of stage 2 (persistent epithelial defect) and 3 (corneal ulcer) neurotrophic keratitis